Aluminum balance in intensive care patients

Journal of Trace Elements in Medicine and Biology

Volumn 14, Issue 4, 2001, Pages 223-227

  Wilhelm, M ^a   Hoelzer, J ^a   Luebbers, K ^b   Stoehr, G ^c   Ohmann, C ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Aluminum; Human; Intensive care; Parenteral solution

Indexed keywords

ACETYLCYSTEINE; ALUMINUM; ANTIBIOTIC AGENT; CATECHOLAMINE; GRAPHITE; TRIFLUPROMAZINE;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD LEVEL; CALCULATION; CLINICAL ARTICLE; COLLOID; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; INTENSIVE CARE; INTRAVENOUS FEEDING; KIDNEY FUNCTION; MALE; PARENTERAL NUTRITION; PRIORITY JOURNAL; QUALITY CONTROL; URINE LEVEL;

EID: 0035000216     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0946-672X(01)80006-7     Document Type: Article

References (15)

1. RECKNAGEL S., BRC€TTER P., CHRISSAFIDOU A., GRAMM H.J., KOTWAS J., R...SICK U. Parenteral aluminum loading in critical care medicine. Part I: aluminum content of infusion solutions and solutions for parenteral nutrition. Infusionsther. Transfusionsmed. 1994; 21, 266-273.
2. PAVANETTO F., GENTA I., CONTI B., MODENAT., MONTANARI L. Aluminum, cadmium and lead in large volume parenterals: contamination levels and sources. Int. J. Pharmaceutics 1989; 54, 143-148.
3. KLEIN G.L. Aluminum in parenteral solutions revisited -again. Am. J. Clin. Nutr. 1995; 61, 449-456.
4. WILHELM M., SPRENGER K.B.G., VOSSAS U., OHNESORGE F.K. Aluminum load in chronic intermittent plasma exchange. J. Toxicol. Clin. Toxicol. 1987; 25, 209-220.
5. WILHELM M., JC€GER D.E., OHNESORGE F.K. Aluminium toxicokinetics. Pharmacology Toxicology. 1990; 66, 4-9.
6. WILHELM M., ZHANG X.J., HAFNER D., OHNESORGE F.K. Single-dose toxicokinetics of aluminum in the rat. Arch. Toxicol. 1992; 66, 700-705.
7. WILHELM M., OHNESORGE F.K. Influence of storage conditions on aluminum concentrations in serum, dialysis fluid, urine, and tap water. J. Anal. Toxicol. 1990; 14, 206-210.
8. KLEIN G.L. The aluminum content of parenteral solutions: current status. Nutr. Rev. 1991; 49, 74-79.
9. WHO International Programme on chemical safety: Aluminium. Environmental health criteria. 1997; 194, 102-103.
10. ASCN/A.S.P.E.N. Working Group on Standards for Aluminum Content of Parenteral Nutrition. Parenteral drug products containing aluminum as an ingredient or a contaminant: response to Food and Drug Administration notice of intent and request for information. J. Parenter. Enter. Nutr. 1991; 15, 194-198.
11. COSTANTINI S., GIORDANO R., IOPPOLO A., MANTOVANI A., BALLANTI P., MOCETTI P., BONUCCI E. Distribution of aluminum following intraperitoneal injection of aluminum lactate in the rat. Pharmacol. Toxicol. 1989; 64, 47-50.
12. NORDAL K.P., DAHL E., ALBRECHTSEN D., HALSE L., LEIVESTAD T., TRETLI S., FLATMARK A: Aluminum accumulation and immunosupressive effect in recipients of kidney transplants. Br. Med. 1988; 297, 1581-1582.
13. ALLAIN P., MADRAS Y., KRARI N., DUCHIER J., COURNOT A., LARCHEVEQUE J. Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate. Br. J. Clin. Pharmacol. 1990; 29(4), 391-395.
14. MISTRY P., VARGHESE Z., POUNDER R.E. Short report: plasma aluminium concentration and 24-hour urinary aluminium excretion before, during and after treatment with sucralfate. Aliment. Pharmacol. Ther. 1991; 5, 549-553.
15. ITTEL T.H., BUDDINGTON B, MILLER N.L., ALFREY A.C. Hyperaluminaemia in critically ill patients: Role of antacid therapy and impaired renal function. Eur. J. Clin. Invest. 1991; 21, 96-102.